Literature DB >> 31525068

Heart Rate and Heart Failure With Preserved Ejection Fraction: Time to Slow β-Blocker Use?

Markus Meyer1, Martin M LeWinter1.   

Abstract

Entities:  

Keywords:  atrial fibrillation; beta blockers; heart failure; heart rate; hypertension

Year:  2019        PMID： 31525068      PMCID： PMC6750011          DOI： 10.1161/CIRCHEARTFAILURE.119.006213

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  28 in total

1.  Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.

Authors:  Viviane M Conraads; Marco Metra; Otto Kamp; Gilles W De Keulenaer; Burkert Pieske; José Zamorano; Panos E Vardas; Michael Böhm; Livio Dei Cas
Journal:  Eur J Heart Fail       Date:  2011-12-06       Impact factor: 15.534

2.  Lenient versus strict rate control in patients with atrial fibrillation.

Authors:  Isabelle C Van Gelder; Hessel F Groenveld; Harry J G M Crijns; Ype S Tuininga; Jan G P Tijssen; A Marco Alings; Hans L Hillege; Johanna A Bergsma-Kadijk; Jan H Cornel; Otto Kamp; Raymond Tukkie; Hans A Bosker; Dirk J Van Veldhuisen; Maarten P Van den Berg
Journal:  N Engl J Med       Date:  2010-03-15       Impact factor: 91.245

3.  Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Rick A Nishimura; Paul Sorajja; Carolyn S P Lam; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2010-06-11       Impact factor: 8.790

4.  Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction.

Authors:  Donald E Selby; Bradley M Palmer; Martin M LeWinter; Markus Meyer
Journal:  J Am Coll Cardiol       Date:  2011-07-05       Impact factor: 24.094

5.  Frequency-dependent left ventricular performance in women and men.

Authors:  Rodrigo V Wainstein; Zion Sasson; Susanna Mak
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-30       Impact factor: 4.733

6.  Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction.

Authors:  Barry A Borlaug; Vojtech Melenovsky; Stuart D Russell; Kristy Kessler; Karel Pacak; Lewis C Becker; David A Kass
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

7.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Authors:  Marcus D Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J Van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jiri Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Journal:  Eur Heart J       Date:  2005-01-09       Impact factor: 29.983

Review 8.  Regulation of coronary blood flow during exercise.

Authors:  Dirk J Duncker; Robert J Bache
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

9.  Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).

Authors:  A Bergström; B Andersson; M Edner; E Nylander; H Persson; U Dahlström
Journal:  Eur J Heart Fail       Date:  2004-06       Impact factor: 15.534

10.  Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure.

Authors:  Rolf Wachter; Stephan Schmidt-Schweda; Dirk Westermann; Heiner Post; Frank Edelmann; Mario Kasner; Claus Lüers; Paul Steendijk; Gerd Hasenfuss; Carsten Tschöpe; Burkert Pieske
Journal:  Eur Heart J       Date:  2009-12       Impact factor: 29.983
View more
  16 in total

1.  Patient-Reported Barriers and Facilitators to Deprescribing Cardiovascular Medications.

Authors:  Parag Goyal; Tatiana Requijo; Birgit Siceloff; Megan J Shen; Ruth Masterson Creber; Sarah N Hilmer; Ian M Kronish; Mark S Lachs; Monika M Safford
Journal:  Drugs Aging       Date:  2020-02       Impact factor: 3.923

2.  Beta-Blocker Use in Hypertension and Heart Failure (A Secondary Analysis of the Systolic Blood Pressure Intervention Trial).

Authors:  Daniel N Silverman; Jeanne du Fay de Lavallaz; Timothy B Plante; Margaret M Infeld; Parag Goyal; Stephen P Juraschek; Geoff B Dougherty; Peter W Callas; Markus Meyer
Journal:  Am J Cardiol       Date:  2021-12-11       Impact factor: 2.778

Review 3.  N-of-1 trials to facilitate evidence-based deprescribing: Rationale and case study.

Authors:  Parag Goyal; Monika M Safford; Sarah N Hilmer; Michael A Steinman; Daniel D Matlock; Mathew S Maurer; Mark S Lachs; Ian M Kronish
Journal:  Br J Clin Pharmacol       Date:  2022-07-13       Impact factor: 3.716

4.  Complex and Potentially Harmful Medication Patterns in Heart Failure with Preserved Ejection Fraction.

Authors:  Lina M Brinker; Matthew C Konerman; Pedram Navid; Michael P Dorsch; Jennifer McNamara; Cristen J Willer; Mary E Tinetti; Scott L Hummel; Parag Goyal
Journal:  Am J Med       Date:  2020-08-18       Impact factor: 4.965

5.  Carvedilol and exercise combination therapy improves systolic but not diastolic function and reduces plasma osteopontin in Col4a3-/- Alport mice.

Authors:  Julian C Dunkley; Camila I Irion; Keyvan Yousefi; Serene A Shehadeh; Guerline Lambert; Krista John-Williams; Keith A Webster; Jeffrey J Goldberger; Lina A Shehadeh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-03-26       Impact factor: 4.733

6.  Association Between β-Blockers and Outcomes in Heart Failure With Preserved Ejection Fraction: Current Insights From the SwedeHF Registry.

Authors:  Markus Meyer; Jeanne Du Fay Lavallaz; Lina Benson; Gianluigi Savarese; Ulf Dahlström; Lars H Lund
Journal:  J Card Fail       Date:  2021-05-08       Impact factor: 5.712

7.  Attitudes toward deprescribing among adults with heart failure with preserved ejection fraction.

Authors:  Pedram Navid; Linh Nguyen; Diana Jaber; Kate Zarzuela; Mahad Musse; Marcos Lu Wang; Tatiana Requijo; Elissa Kozlov; Ruth M Masterson Creber; Sarah N Hilmer; Mark Lachs; Parag Goyal
Journal:  J Am Geriatr Soc       Date:  2021-05-12       Impact factor: 7.538

8.  Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial).

Authors:  Patricia Palau; Julia Seller; Eloy Domínguez; Inés Gómez; José María Ramón; Clara Sastre; Rafael de la Espriella; Enrique Santas; Gema Miñana; Francisco J Chorro; José Ramón González-Juanatey; Julio Núñez
Journal:  Clin Cardiol       Date:  2020-02-19       Impact factor: 2.882

Review 9.  Heart failure with preserved ejection fraction: insights from recent clinical researches.

Authors:  Mi-Na Kim; Seong-Mi Park
Journal:  Korean J Intern Med       Date:  2020-04-29       Impact factor: 2.884

10.  Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.

Authors:  Min Soo Ahn; Byung Su Yoo; Jung Woo Son; Min Heui Yu; Dae Ryong Kang; Hae Young Lee; Eun Seok Jeon; Jae Joong Kim; Shung Chull Chae; Sang Hong Baek; Seok Min Kang; Dong Ju Choi; Kye Hun Kim; Myeong Chan Cho; Seong Yoon Kim
Journal:  J Korean Med Sci       Date:  2020-08-24       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.